Literature DB >> 19562738

Tumour suppression by p53: the importance of apoptosis and cellular senescence.

Valentina Zuckerman1, Kamil Wolyniec, Ronit V Sionov, Sue Haupt, Ygal Haupt.   

Abstract

p53 is regarded as a central player in tumour suppression, as it controls programmed cell death (apoptosis) as well as cellular senescence. While apoptosis eliminates cells at high risk for oncogenic transformation, senescence acts as a barrier to tumourigenesis by imposing irreversible cell cycle arrest. p53 can act directly or indirectly at multiple levels of the tumour suppression network by invoking a myriad of mechanisms. p53 induces the extrinsic and intrinsic apoptotic pathways at multiple steps to ensure an efficient death response. This response involves transcriptional activation or repression of target genes, as well as the recently identified microRNAs, and transcription-independent functions. Importantly, p53 loss of function is required for tumour maintenance. Therefore, therapeutic strategies aimed at reactivation of p53 in tumours emerge as a promising approach for the treatment of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562738     DOI: 10.1002/path.2584

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  80 in total

1.  Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors:  Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

2.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

3.  Alternative fuel--another role for p53 in the regulation of metabolism.

Authors:  Karen H Vousden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-14       Impact factor: 11.205

Review 4.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

5.  P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).

Authors:  Zhongyan Hua; Yue Zhan; Simeng Zhang; Yudi Dong; Min Jiang; Fei Tan; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Apoptosis       Date:  2018-08       Impact factor: 4.677

6.  MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner.

Authors:  Boya Liu; Jingjie Yi; Xin Yang; Lu Liu; Xinlin Lou; Zeyuan Zhang; Hao Qi; Zhe Wang; Junhua Zou; Wei-Guo Zhu; Wei Gu; Jianyuan Luo
Journal:  Oncogene       Date:  2018-12-07       Impact factor: 9.867

7.  Increase developmental plasticity of human keratinocytes with gene suppression.

Authors:  Shengwen Calvin Li; Yangsun Jin; William G Loudon; Yahui Song; Zhiwei Ma; Leslie P Weiner; Jiang F Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

8.  Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.

Authors:  Ulf Lützen; Yi Zhao; Katja Lucht; Maaz Zuhayra; Marlies Marx; Ingolf Cascorbi; Juraj Culman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-23       Impact factor: 3.000

9.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

10.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.